DE60222143D1 - USE OF NON-FEMINATING ESTROGENES AS RETINOPROTECTIVE AGENTS FOR THE TREATMENT OF GLAUCOMA - Google Patents
USE OF NON-FEMINATING ESTROGENES AS RETINOPROTECTIVE AGENTS FOR THE TREATMENT OF GLAUCOMAInfo
- Publication number
- DE60222143D1 DE60222143D1 DE60222143T DE60222143T DE60222143D1 DE 60222143 D1 DE60222143 D1 DE 60222143D1 DE 60222143 T DE60222143 T DE 60222143T DE 60222143 T DE60222143 T DE 60222143T DE 60222143 D1 DE60222143 D1 DE 60222143D1
- Authority
- DE
- Germany
- Prior art keywords
- feminating
- estrogenes
- glaucoma
- treatment
- retinoprotective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31722501P | 2001-09-05 | 2001-09-05 | |
| US317225P | 2001-09-05 | ||
| PCT/US2002/027969 WO2003020284A1 (en) | 2001-09-05 | 2002-09-03 | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60222143D1 true DE60222143D1 (en) | 2007-10-11 |
| DE60222143T2 DE60222143T2 (en) | 2008-06-05 |
Family
ID=23232682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60222143T Expired - Lifetime DE60222143T2 (en) | 2001-09-05 | 2002-09-03 | USE OF NON-FEMINATING ESTROGENES AS RETINOPROTECTIVE AGENTS FOR THE TREATMENT OF GLAUCOMA |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1423125B1 (en) |
| JP (1) | JP2005501888A (en) |
| KR (1) | KR100894385B1 (en) |
| CN (1) | CN1551773A (en) |
| AR (1) | AR038451A1 (en) |
| AT (1) | ATE371455T1 (en) |
| AU (1) | AU2002326807B2 (en) |
| BR (1) | BR0212274A (en) |
| CA (1) | CA2458468C (en) |
| DE (1) | DE60222143T2 (en) |
| ES (1) | ES2289134T3 (en) |
| HK (1) | HK1064947A1 (en) |
| MX (1) | MXPA04002098A (en) |
| PL (1) | PL206249B1 (en) |
| TW (1) | TWI320712B (en) |
| WO (1) | WO2003020284A1 (en) |
| ZA (1) | ZA200401313B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040214806A1 (en) | 2002-09-03 | 2004-10-28 | Iok-Hou Pang | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| WO2004093882A1 (en) * | 2003-04-18 | 2004-11-04 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
| WO2004091630A1 (en) * | 2003-04-18 | 2004-10-28 | Advanced Medicine Research Institute | Remedies for diseases to be applied to eye |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993010141A2 (en) * | 1991-11-22 | 1993-05-27 | Alcon Laboratories, Inc. | Angiostatic steroids |
| US6197833B1 (en) * | 1995-07-24 | 2001-03-06 | Apollo Biopharmaceutics, Inc. | Neuroprotective effects of polycyclic phenolic compounds |
| US5521168A (en) * | 1994-10-13 | 1996-05-28 | Alcon Laboratories, Inc. | Estrogen metabolites for lowering intraocular pressure |
| AU8838601A (en) * | 2000-11-27 | 2002-06-03 | Entremed Inc | Antiangiogenic agents |
-
2002
- 2002-08-21 TW TW091118916A patent/TWI320712B/en not_active IP Right Cessation
- 2002-08-29 AR ARP020103261A patent/AR038451A1/en unknown
- 2002-09-03 EP EP02761551A patent/EP1423125B1/en not_active Expired - Lifetime
- 2002-09-03 WO PCT/US2002/027969 patent/WO2003020284A1/en active IP Right Grant
- 2002-09-03 PL PL374243A patent/PL206249B1/en not_active IP Right Cessation
- 2002-09-03 DE DE60222143T patent/DE60222143T2/en not_active Expired - Lifetime
- 2002-09-03 ES ES02761551T patent/ES2289134T3/en not_active Expired - Lifetime
- 2002-09-03 AT AT02761551T patent/ATE371455T1/en not_active IP Right Cessation
- 2002-09-03 MX MXPA04002098A patent/MXPA04002098A/en active IP Right Grant
- 2002-09-03 BR BR0212274-0A patent/BR0212274A/en not_active Application Discontinuation
- 2002-09-03 CA CA2458468A patent/CA2458468C/en not_active Expired - Fee Related
- 2002-09-03 KR KR1020047003273A patent/KR100894385B1/en not_active IP Right Cessation
- 2002-09-03 JP JP2003524591A patent/JP2005501888A/en active Pending
- 2002-09-03 CN CNA028173740A patent/CN1551773A/en active Pending
- 2002-09-03 AU AU2002326807A patent/AU2002326807B2/en not_active Ceased
-
2004
- 2004-02-18 ZA ZA200401313A patent/ZA200401313B/en unknown
- 2004-10-11 HK HK04107793A patent/HK1064947A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100894385B1 (en) | 2009-04-22 |
| EP1423125A4 (en) | 2005-02-09 |
| MXPA04002098A (en) | 2004-06-07 |
| HK1064947A1 (en) | 2005-02-08 |
| PL206249B1 (en) | 2010-07-30 |
| CN1551773A (en) | 2004-12-01 |
| DE60222143T2 (en) | 2008-06-05 |
| PL374243A1 (en) | 2005-10-03 |
| WO2003020284A1 (en) | 2003-03-13 |
| ZA200401313B (en) | 2005-05-11 |
| EP1423125B1 (en) | 2007-08-29 |
| EP1423125A1 (en) | 2004-06-02 |
| CA2458468C (en) | 2010-08-24 |
| CA2458468A1 (en) | 2003-03-13 |
| ES2289134T3 (en) | 2008-02-01 |
| AR038451A1 (en) | 2005-01-19 |
| AU2002326807B2 (en) | 2007-08-23 |
| JP2005501888A (en) | 2005-01-20 |
| KR20040033012A (en) | 2004-04-17 |
| TWI320712B (en) | 2010-02-21 |
| ATE371455T1 (en) | 2007-09-15 |
| BR0212274A (en) | 2004-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE308997T1 (en) | AGENTS FOR THE TREATMENT OF DISEASES OF THE ESOPHAUS | |
| ATE292971T1 (en) | (S,S)-REBOXETINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES | |
| DE60124302D1 (en) | THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES | |
| DE602004028763D1 (en) | TE FOR THE TREATMENT OF VIRUS DISEASES | |
| DE69903543D1 (en) | FORMULATIONS FOR THE TREATMENT OF REFLUX GENTLE EYES | |
| DE60235083D1 (en) | SUBSTITUTED TETRACYCLIN COMPOUNDS FOR THE TREATMENT OF MALARIA | |
| DE60019556D1 (en) | 2-AMINO-BENZOXAZINE DERIVATIVES FOR THE TREATMENT OF FATIBILITY | |
| DE60234760D1 (en) | PHENYLINDOLE FOR THE TREATMENT OF HIV | |
| DE60325770D1 (en) | USE OF RIMEXOLONE FOR THE TREATMENT OF EYE DRYNESS | |
| DE60204466D1 (en) | INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES | |
| DE60019555D1 (en) | 2-OXY-BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF FATIBILITY | |
| DE10082139T1 (en) | Composition for the treatment of friction pairs | |
| DE60136477D1 (en) | RETINOIDES FOR THE TREATMENT OF EMPHYSEM | |
| DE60218451D1 (en) | 15-KETO-PROSTAGLANDINE FOR THE TREATMENT OF DRUG-INDUCED OBSTIPATION | |
| DE60228317D1 (en) | N-ARYL-N'-ARYLCYCLOALKYL UREA AS MCH ANTAGONISTS FOR THE TREATMENT OF FATIBILITY | |
| DE60238765D1 (en) | CARBAMATE COMPOUNDS FOR THE TREATMENT OF PAIN | |
| DE50105735D1 (en) | CHLOROZAZAZONE FOR THE TREATMENT OF PSORIASIS | |
| DE50205466D1 (en) | SUBSTITUTED 2,5-DIAMIDOINDOLE AS ECE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | |
| DE60103685D1 (en) | Treatment of poriomania | |
| DE50212649D1 (en) | USE OF DESOXYPEGANINE FOR THE TREATMENT OF CLINICAL DEPRESSION | |
| ATE443060T1 (en) | BENZOAQUINOLINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA AND MIOPSIGHTEDNESS | |
| DE60222143D1 (en) | USE OF NON-FEMINATING ESTROGENES AS RETINOPROTECTIVE AGENTS FOR THE TREATMENT OF GLAUCOMA | |
| DE60120961D1 (en) | DISULFIDE DERIVATIVES USE FOR THE TREATMENT OF ALLERGIC DISEASES | |
| ATE285764T1 (en) | RIVASTIGMINE FOR THE TREATMENT OF EYE DISEASES | |
| DE60124093D1 (en) | S-methyl-dihydro-ziprasidone for the treatment of eye diseases. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |